Violeta Dopsaj

595 total citations
46 papers, 447 citations indexed

About

Violeta Dopsaj is a scholar working on Hematology, Rehabilitation and Nephrology. According to data from OpenAlex, Violeta Dopsaj has authored 46 papers receiving a total of 447 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Hematology, 10 papers in Rehabilitation and 9 papers in Nephrology. Recurrent topics in Violeta Dopsaj's work include Exercise and Physiological Responses (10 papers), Iron Metabolism and Disorders (8 papers) and Muscle metabolism and nutrition (5 papers). Violeta Dopsaj is often cited by papers focused on Exercise and Physiological Responses (10 papers), Iron Metabolism and Disorders (8 papers) and Muscle metabolism and nutrition (5 papers). Violeta Dopsaj collaborates with scholars based in Serbia, Russia and Romania. Violeta Dopsaj's co-authors include Milivoj Dopsaj, Jelena Martinović, Jelena Kotur‐Stevuljević, Aleksandra Stefanović, Ana Vujović, Nataša Bogavac‐Stanojević, Sanja Simić‐Ogrizović, Zorana Jelić‐Ivanović, Slavica Spasić and Lidija Memon and has published in prestigious journals such as PLoS ONE, International Journal of Molecular Sciences and British Journal of Sports Medicine.

In The Last Decade

Violeta Dopsaj

45 papers receiving 433 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Violeta Dopsaj Serbia 13 82 81 74 67 64 46 447
Y O Schumacher Germany 14 167 2.0× 182 2.2× 103 1.4× 21 0.3× 205 3.2× 20 751
Mirjana Zlatković‐Švenda Serbia 11 102 1.2× 41 0.5× 25 0.3× 32 0.5× 12 0.2× 39 502
Adel Al‐Awadhi Kuwait 15 90 1.1× 42 0.5× 34 0.5× 9 0.1× 12 0.2× 44 530
Taner Bayraktaroğlu Türkiye 12 22 0.3× 177 2.2× 20 0.3× 43 0.6× 15 0.2× 71 659
Marvin M. Adner United States 13 73 0.9× 202 2.5× 50 0.7× 28 0.4× 100 1.6× 20 633
Guenter Hoefle Austria 14 8 0.1× 109 1.3× 29 0.4× 35 0.5× 28 0.4× 17 652
Daniele Canale Brazil 15 17 0.2× 44 0.5× 13 0.2× 149 2.2× 12 0.2× 29 553
Özgür Akgül Türkiye 16 100 1.2× 23 0.3× 9 0.1× 46 0.7× 13 0.2× 37 585
Annemarie Jansen Netherlands 8 172 2.1× 66 0.8× 25 0.3× 9 0.1× 12 0.2× 8 749
Shogo Kato Japan 10 13 0.2× 72 0.9× 8 0.1× 43 0.6× 13 0.2× 14 454

Countries citing papers authored by Violeta Dopsaj

Since Specialization
Citations

This map shows the geographic impact of Violeta Dopsaj's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Violeta Dopsaj with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Violeta Dopsaj more than expected).

Fields of papers citing papers by Violeta Dopsaj

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Violeta Dopsaj. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Violeta Dopsaj. The network helps show where Violeta Dopsaj may publish in the future.

Co-authorship network of co-authors of Violeta Dopsaj

This figure shows the co-authorship network connecting the top 25 collaborators of Violeta Dopsaj. A scholar is included among the top collaborators of Violeta Dopsaj based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Violeta Dopsaj. Violeta Dopsaj is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Stanisavljević, Nataša, Ljudmila Stojanovich, Aleksandra Djoković, et al.. (2022). Asymmetric Dimethylarginine Is a Marker of Endothelial Dysfunction in Thrombotic Antiphospholipid Syndrome Patients. International Journal of Molecular Sciences. 23(20). 12309–12309. 3 indexed citations
3.
Dopsaj, Violeta, Mirjana Kovač, Vesna Mandić, et al.. (2021). Phosphatidylserine Exposing Extracellular Vesicles in Pre-eclamptic Patients. Frontiers in Medicine. 8. 761453–761453. 8 indexed citations
4.
5.
Šarić, M., et al.. (2018). Anti-annexin A5 antibodies and 25-hydroxy-cholecalciferol in female patients with primary antiphospholipid syndrome. Clinical Rheumatology. 37(12). 3359–3364. 2 indexed citations
6.
Alempijević, Tamara, Simon Zec, Vladimir Milivojević, et al.. (2016). Erythropoietin in Predicting Prognosis in Patients with Acute-on- Chronic Liver Failure. Journal of Gastrointestinal and Liver Diseases. 25(4). 473–479. 2 indexed citations
7.
8.
Stanisavljević, Nataša, Ljudmila Stojanovich, Dragomir Marisavljević, et al.. (2016). Lipid peroxidation as risk factor for endothelial dysfunction in antiphospholipid syndrome patients. Clinical Rheumatology. 35(10). 2485–2493. 16 indexed citations
9.
Memon, Lidija, Vesna Spasojević‐Kalimanovska, Jelena Kotur‐Stevuljević, et al.. (2013). Are Levels of NT-proBNP and SDMA Useful to Determine Diastolic Dysfunction in Chronic Kidney Disease and Renal Transplant Patients?. Journal of Clinical Laboratory Analysis. 27(6). 461–470. 7 indexed citations
10.
Kotur‐Stevuljević, Jelena, Sanja Simić‐Ogrizović, Violeta Dopsaj, et al.. (2012). A hazardous link between malnutrition, inflammation and oxidative stress in renal patients. Clinical Biochemistry. 45(15). 1202–1205. 29 indexed citations
11.
Dopsaj, Violeta, et al.. (2012). Evaluation of derived Coulter red blood cell parameters for the assessment of iron deficiency in adults with congenital heart disease. International Journal of Laboratory Hematology. 34(5). 461–472. 11 indexed citations
12.
Branch, Donald R., Violeta Dopsaj, Veljko Veljković, et al.. (2011). Can natural antibodies to VIP or VIP-like HIV-1 glycoprotein facilitate prevention and supportive treatment of breast cancer?. Medical Hypotheses. 77(3). 404–408. 4 indexed citations
13.
Vekić, Jelena, Aleksandra Zeljković, Nataša Bogavac‐Stanojević, et al.. (2011). Cox proportional hazard model analysis of survival in end-stage renal disease patients with small-sized high-density lipoprotein particles. Clinical Biochemistry. 44(8-9). 635–641. 10 indexed citations
14.
Dopsaj, Violeta, Milivoj Dopsaj, Donald R. Branch, et al.. (2011). Physical Activity and Natural Anti-VIP Antibodies: Potential Role in Breast and Prostate Cancer Therapy. PLoS ONE. 6(11). e28304–e28304. 8 indexed citations
15.
Dopsaj, Violeta, et al.. (2010). Gender-Specific Oxidative Stress Parameters. International Journal of Sports Medicine. 32(1). 14–19. 16 indexed citations
16.
Martinović, Jelena, et al.. (2010). Haematological and iron-related parameters in male and female athletes according to different metabolic energy demands. European Journal of Applied Physiology. 111(3). 449–458. 32 indexed citations
17.
Martinović, Jelena, Violeta Dopsaj, Jelena Kotur‐Stevuljević, et al.. (2010). Oxidative Stress Biomarker Monitoring in Elite Women Volleyball Athletes During a 6-Week Training Period. The Journal of Strength and Conditioning Research. 25(5). 1360–1367. 25 indexed citations
18.
Dopsaj, Violeta, Nataša Bogavac‐Stanojević, Dragan Vasić, et al.. (2009). Excluding deep venous thrombosis in symptomatic outpatients: is fibrin monomer aid to D-dimer analysis?. Blood Coagulation & Fibrinolysis. 20(7). 546–551. 6 indexed citations
19.
Ležaić, Višnja, et al.. (2009). Efficacy of hyperphosphatemia control in the progression of chronic renal failure and the prevalence of cardiovascular calcification. Clinical Nephrology. 71(1). 21–29. 17 indexed citations
20.
Martinović, Jelena, Violeta Dopsaj, Milivoj Dopsaj, et al.. (2009). Long-term Effects of Oxidative Stress in Volleyball Players. International Journal of Sports Medicine. 30(12). 851–856. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Y O Schumacher Breakdown of academic impact, for papers by Mirjana Zlatković‐Švenda Breakdown of academic impact, for papers by Adel Al‐Awadhi Breakdown of academic impact, for papers by Taner Bayraktaroğlu Breakdown of academic impact, for papers by Marvin M. Adner Breakdown of academic impact, for papers by Guenter Hoefle Breakdown of academic impact, for papers by Daniele Canale Breakdown of academic impact, for papers by Özgür Akgül Breakdown of academic impact, for papers by Annemarie Jansen Breakdown of academic impact, for papers by Shogo Kato
Rankless by CCL
2026